• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由SP-40,40、载脂蛋白A-I和脂质组成的高密度脂蛋白在补体膜攻击复合物形成中的作用。

The role of HDL consisting of SP-40,40, apo A-I, and lipids in the formation of SMAC of complement.

作者信息

Choi-Miura N H, Sakamoto T, Tobe T, Nakano Y, Tomita M

机构信息

Department of Physiological Chemistry, School of Pharmaceutical Sciences, Showa University, Tokyo.

出版信息

J Biochem. 1993 Apr;113(4):484-7. doi: 10.1093/oxfordjournals.jbchem.a124070.

DOI:10.1093/oxfordjournals.jbchem.a124070
PMID:8514737
Abstract

Soluble membrane attack complex (SMAC, SC5b-9) of complement contained apolipoprotein A-I (apo A-I) and lipids. Since SC5b-9 contained no apolipoprotein A-II (apo A-II), the incorporation of apo A-I and lipids into SC5b-9 was not caused by a non-specific binding of high-density lipoprotein (HDL). The incorporation of apo A-I into SC5b-9 was confirmed by a double agar diffusion immuno-assay. SC5b-9 contained one molecule of apo A-I and 3.5% lipids by weight. The composition of the lipids was phospholipid: total cholesterol: triglyceride = 47.5:45.0:7.5, and the ratio of free cholesterol:esterified cholesterol was 22.3:77.7. Since SC5b-7 contained apo A-I and SC5b-9 free of SP-40,40 contained no apo A-I, the HDL consisting of SP-40,40, apo A-I, and lipids was incorporated into SMAC at the stage of SC5b-7 via SP-40,40 as a binding site.

摘要

补体的可溶性膜攻击复合物(SMAC,SC5b-9)含有载脂蛋白A-I(apo A-I)和脂质。由于SC5b-9不含载脂蛋白A-II(apo A-II),因此apo A-I和脂质掺入SC5b-9并非由高密度脂蛋白(HDL)的非特异性结合所致。通过双向琼脂扩散免疫测定法证实了apo A-I掺入SC5b-9。SC5b-9按重量计含有一分子apo A-I和3.5%的脂质。脂质的组成是磷脂:总胆固醇:甘油三酯 = 47.5:45.0:7.5,游离胆固醇与酯化胆固醇的比例为22.3:77.7。由于SC5b-7含有apo A-I且不含SP-40,40的SC5b-9不含apo A-I,由SP-40,40、apo A-I和脂质组成的HDL在SC5b-7阶段通过SP-40,40作为结合位点掺入SMAC。

相似文献

1
The role of HDL consisting of SP-40,40, apo A-I, and lipids in the formation of SMAC of complement.由SP-40,40、载脂蛋白A-I和脂质组成的高密度脂蛋白在补体膜攻击复合物形成中的作用。
J Biochem. 1993 Apr;113(4):484-7. doi: 10.1093/oxfordjournals.jbchem.a124070.
2
Elevated complement activities of sera from patients with high density lipoprotein deficiency (Tangier disease): the presence of normal level of clusterin and the possible implication in the atherosclerosis.高密度脂蛋白缺乏症(丹吉尔病)患者血清补体活性升高:簇集素水平正常及其在动脉粥样硬化中的可能意义。
Clin Exp Immunol. 1993 Aug;93(2):242-7. doi: 10.1111/j.1365-2249.1993.tb07973.x.
3
Incorporation of SP-40,40 into the soluble membrane attack complex (SMAC, SC5b-9) of complement.将SP-40,40整合到补体的可溶性膜攻击复合物(SMAC,SC5b-9)中。
Int Immunol. 1990;2(5):413-7. doi: 10.1093/intimm/2.5.413.
4
Clusterin (complement lysis inhibitor) forms a high density lipoprotein complex with apolipoprotein A-I in human plasma.
J Biol Chem. 1991 Jun 15;266(17):11030-6.
5
Characterization of apolipoprotein A-I- and A-II-containing lipoproteins in a new case of high density lipoprotein deficiency resembling Tangier disease and their effects on intracellular cholesterol efflux.在一例类似丹吉尔病的新的高密度脂蛋白缺乏病例中,对含载脂蛋白A-I和A-II的脂蛋白的特征分析及其对细胞内胆固醇流出的影响。
J Clin Invest. 1993 Feb;91(2):522-9. doi: 10.1172/JCI116231.
6
Functional and structural properties of lipid-associated apolipoprotein J (clusterin).脂质相关载脂蛋白J(簇集蛋白)的功能和结构特性。
Biochem J. 1999 Dec 1;344 Pt 2(Pt 2):375-83.
7
SP-40,40, a newly identified normal human serum protein found in the SC5b-9 complex of complement and in the immune deposits in glomerulonephritis.SP-40,40,一种新发现的正常人血清蛋白,存在于补体的SC5b-9复合物及肾小球肾炎的免疫沉积物中。
J Clin Invest. 1988 Jun;81(6):1858-64. doi: 10.1172/JCI113531.
8
Localization of terminal complement components S-protein and SP-40,40 in renal biopsies.终末补体成分S蛋白和SP-40,40在肾活检组织中的定位
Pathology. 1989 Oct;21(4):275-8. doi: 10.3109/00313028909061073.
9
Characterization of a human high density lipoprotein-associated protein, NA1/NA2. Identity with SP-40,40, an inhibitor of complement-mediated cytolysis.
Arterioscler Thromb. 1991 May-Jun;11(3):645-52. doi: 10.1161/01.atv.11.3.645.
10
Hyperthyroidism influences the distribution and apolipoprotein A composition of the high density lipoproteins in man.甲状腺功能亢进影响人体高密度脂蛋白的分布和载脂蛋白A的组成。
J Clin Endocrinol Metab. 1985 Nov;61(5):882-9. doi: 10.1210/jcem-61-5-882.

引用本文的文献

1
Complement activation in the context of stem cells and tissue repair.干细胞与组织修复背景下的补体激活
World J Stem Cells. 2015 Sep 26;7(8):1090-108. doi: 10.4252/wjsc.v7.i8.1090.
2
Elevated complement activities of sera from patients with high density lipoprotein deficiency (Tangier disease): the presence of normal level of clusterin and the possible implication in the atherosclerosis.高密度脂蛋白缺乏症(丹吉尔病)患者血清补体活性升高:簇集素水平正常及其在动脉粥样硬化中的可能意义。
Clin Exp Immunol. 1993 Aug;93(2):242-7. doi: 10.1111/j.1365-2249.1993.tb07973.x.
3
High-density lipoproteins can act as carriers of glycophosphoinositol lipid-anchored CD59 in human plasma.
高密度脂蛋白可作为人血浆中糖基磷脂酰肌醇脂质锚定的CD59的载体。
Immunology. 1994 May;82(1):28-33.